KWA
GILD icon

Kingswood Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Kingswood Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
10,686
+1,805
+20% +$238K 0.05% 341
2026
Q1 		$1.24M Buy
8,881
+214
+2% +$30K 0.06% 330
2025
Q4 		$1.06M Buy
8,667
+93
+1% +$11.3K 0.05% 337
2025
Q3 		$952K Sell
8,574
-1,405
-14% -$160K 0.06% 323
2025
Q2 		$1.11M Sell
9,979
-3,001
-23% -$319K 0.09% 248
2025
Q1 		$1.45M Sell
12,980
-1,611
-11% -$166K 0.13% 178
2024
Q4 		$1.35M Sell
14,591
-7,735
-35% -$696K 0.1% 212
2024
Q3 		$1.87M Buy
22,326
+420
+2% +$32K 0.13% 179
2024
Q2 		$1.5M Buy
21,906
+10,412
+91% +$695K 0.14% 154
2024
Q1 		$842K Sell
11,494
-10,259
-47% -$789K 0.1% 236
2023
Q4 		$1.76M Buy
21,753
+10,646
+96% +$828K 0.2% 118
2023
Q3 		$832K Buy
11,107
+7,760
+232% +$597K 0.14% 166
2023
Q2 		$258K Buy
+3,347
New +$267K 0.08% 218

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kingswood Wealth Advisors's GILD Position: Q2 2026 in Review

Kingswood Wealth Advisors increased its Gilead Sciences (GILD) stake by 20% in Q2 2026, buying an estimated $238K and bringing the position to 10,686 shares worth $1.35M. The position accounts for 0.05% of the portfolio, ranked #341.

Kingswood Wealth Advisors first reported a position in GILD in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.87M in Q3 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kingswood Wealth Advisors held 10,686 shares of Gilead Sciences worth $1.35M as of Q2 2026.
  • Kingswood Wealth Advisors bought 1,805 Gilead Sciences shares in Q2 2026, an estimated $238K.
  • Gilead Sciences made up 0.05% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #341 holding.
  • Kingswood Wealth Advisors first reported a position in Gilead Sciences in Q2 2023 and has held it in 13 quarters since.
  • Kingswood Wealth Advisors's Gilead Sciences position peaked at $1.87M in Q3 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.